Graybug Vision, Inc.
(NASDAQ : GRAY)

... ...
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.13%163.560.7%$1160.35m
PFEPfizer Inc. 0.19%36.550.9%$1138.06m
LLYEli Lilly & Co. 1.95%206.301.1%$934.48m
ABBVAbbVie, Inc. -0.34%110.881.9%$732.28m
BMYBristol-Myers Squibb Co. 0.61%64.571.0%$679.31m
MRKMerck & Co., Inc. -0.26%80.970.7%$677.96m
AZNAstraZeneca Plc 1.33%53.251.2%$669.74m
ARCTArcturus Therapeutics Holdings, Inc. 6.16%67.700.0%$229.98m
GRTSGritstone Oncology, Inc. 6.11%27.110.0%$211.05m
VTRSViatris, Inc. 0.69%17.430.0%$193.56m
RPRXRoyalty Pharma Plc 1.47%51.160.2%$174.27m
NVSNovartis AG 0.06%96.940.2%$174.04m
GSKGlaxoSmithKline Plc 1.54%38.360.2%$154.42m
SNYSanofi 0.10%49.690.2%$134.98m
RGENRepligen Corp. 1.11%219.326.9%$78.39m

Company Profile

Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA.